Atlas Trials

Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).

Clinical trial NCT06297512 · RECRUITING

Trial details

NCT number
NCT06297512
Sponsor
Iacopo Sardi
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma
Start date
2022-12-09
Primary completion
2027-11-09
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.